Literature DB >> 25491620

The levels of serum pentraxin3, CRP, fetuin-A, and insulin in patients with psoriasis.

S Uysal1, F M Yılmaz, K Karatoprak, F Artüz, N U Cumbul.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the relationship between disease severity and biochemical parameters such as pentraxin3, CRP, fetuin-A, insulin and HOMA-IR levels in patients with psoriasis. PATIENTS AND METHODS: This study included 58 patients with psoriasis and 30 healthy controls admitted to Ankara Numune Teaching and Research Hospital between January 2011-August 2012. Serum pentraxin3, CRP, fetuin-A and insulin concentrations were determined. Also, HOMA-IR values were calculated.
RESULTS: The serum values for CRP, insulin, HOMA-IR, pentraxin-3 and fetuin-A in patients with psoriasis were elevated than control subjects (p values=0.002, 0.003, 0.003, 0.006 vs 0.007, respectively). According to the PASI score, patients were divided into three groups, minimal, moderate and severe psoriasis. There were positive correlation between the levels of CRP and insulin, HOMA-IR, PASI score. In addition, PASI score values were positively correlated with insulin, HOMA-IR and fetuin-A levels.
CONCLUSIONS: Elevated levels of pentraxin3, CRP, fetuin-A, insulin and HOMA-IR might play a role in the pathogenesis of psoriasis. Higher CRP, fetuin-A, insulin and HOMA-IR concentrations were associated with the severity of the psoriasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25491620

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  12 in total

1.  Evaluation of Serum Fetuin-A and Osteoprotegerin Levels in Patients with Psoriasis.

Authors:  Mehmet Genc; Murat Can; Berrak Guven; Saniye Cinar; Cagatay Buyukuysal; Bilgehan Acikgoz; Ayca Gorkem Mungan; Serefden Acikgoz
Journal:  Indian J Clin Biochem       Date:  2016-05-06

2.  Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis.

Authors:  Ufuk İlgen; Müçteba Enes Yayla; Nurşen Düzgün
Journal:  Clin Rheumatol       Date:  2016-11-22       Impact factor: 2.980

Review 3.  Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations.

Authors:  Kerstin Wolk; Robert Sabat
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

4.  Trace elements and oxidative stress status in patients with psoriasis.

Authors:  Adnan Kirmit; Saadet Kader; Mustafa Aksoy; Ceylan Bal; Cemil Nural; Oruç Aslan
Journal:  Postepy Dermatol Alergol       Date:  2020-04-07       Impact factor: 1.837

5.  C-reactive protein serum level in patients with psoriasis before and after treatment with narrow-band ultraviolet B.

Authors:  Mahmoud Farshchian; Akram Ansar; Mohammadreza Sobhan; Valiollah Hoseinpoor
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

6.  Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

Authors:  Gia Deyab; Ingrid Hokstad; Jon Elling Whist; Milada Cvancarova Småstuen; Stefan Agewall; Torstein Lyberg; Barbara Bottazzi; Pier Luigi Meroni; Roberto Leone; Gunnbjorg Hjeltnes; Ivana Hollan
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

Review 7.  Adipokines in the Skin and in Dermatological Diseases.

Authors:  Dóra Kovács; Fruzsina Fazekas; Attila Oláh; Dániel Törőcsik
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

8.  Metabolic syndrome and insulin resistance in pre-pubertal children with psoriasis.

Authors:  Francesca Caroppo; Alfonso Galderisi; Laura Ventura; Anna Belloni Fortina
Journal:  Eur J Pediatr       Date:  2021-01-22       Impact factor: 3.183

9.  Serum markers for asymptomatic atherosclerosis in Egyptian psoriatic patients: study controlled by Doppler estimation of carotid intima-media thickness.

Authors:  Hanan Hassan Sabry; Jehan Hassan Sabry; Aliaa El Husseiny Daifalla; Essam Mohamed Akl; Ahmed Mohamed Hamed; Ahmed Abd Allah Torky
Journal:  Vasc Health Risk Manag       Date:  2018-07-09

10.  Alarmins HMGB1, IL-33, S100A7, and S100A12 in Psoriasis Vulgaris.

Authors:  Pavel Borsky; Zdenek Fiala; Ctirad Andrys; Martin Beranek; Kvetoslava Hamakova; Andrea Malkova; Tereza Svadlakova; Jan Krejsek; Vladimir Palicka; Lenka Borska; Vit Rehacek
Journal:  Mediators Inflamm       Date:  2020-04-15       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.